All analyses

Incyte Corporation (INCY) Stock Analysis

Score A+

Compounder · Grade A · Bullish

Healthcare · Biotechnology

$95.86

Fair Value

$179.39

+87.1%

Conviction

10/10

Quality

A

Classification

Compounder

Investment Thesis

High quantitative score: Solid company with strong risk/reward at 10.0:1.

For New Investors

Quantitative score: high

For Current Holders

Quantitative score: neutral

Buy if

  • Price drops 15-20% (improves asymmetry)
  • Bull scenario catalysts materialize
  • Market-wide correction creates opportunity

Sell if

  • Bear scenario triggers occur
  • Quality metrics deteriorate (ROIC declining)
  • Better alternatives emerge

Valuation

Fair Value estimate: $179.39 (+87.1%). Significantly undervalued.

PEG-Based EPS

$191.72

FCF DCF Model

$191.72

EV/EBITDA

$191.72

Blended Fair Value

$179.39

Confidence

High

Methods

PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA

Quality Analysis

A

115/120 points

Investable

ROE (3Y Avg)

12.4%

ROIC-WACC Spread

10.8%

D/E Ratio

0.0x

Current Ratio

3.3x

Interest Coverage

553x

FCF Positive Years

3/3

Quality Flags

  • Low ROE: 12.5% (need >15%, got 15/20 pts)

Market Sentiment

Wall Street Consensus

$108.50

+13.2% Upside

22 analysts

Range: $90.00$135.00

Rating: Buy

Our model is slightly more bullish than Wall Street.

Trend & Technical

Bullish

Price ($96.00) is 1.0% above SMA 200 ($95.06). Bullish trend confirmed.

Technical Score73/100

Tech Score 73/100 — Strong technical setup. Trend, momentum, and positioning aligned bullish.

Risk & Reward

Asymmetry Ratio

10.00:1

Expected Return

+109.4%

Bull Upside

+200.0%

Bear Downside

-10.0%

Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside.

Verdict: Very Favorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of INCY?

Based on our multi-method conviction analysis, the estimated fair value of Incyte Corporation (INCY) is $179.39. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is high.

Is INCY a buy, sell, or hold?

INCY currently has a STRONG_BUY rating with a conviction score of 10/10. High quantitative score: Solid company with strong risk/reward at 10.0:1. Quantitative score: high.

Is INCY a high-quality stock?

Incyte Corporation has a quality grade of A (115/120 points), rated as Investable. Key metrics include ROE of 12.4%, ROIC-WACC spread of 10.8%, and D/E ratio of 0.0x.

What type of stock is INCY?

INCY is classified as a "compounder" in our framework. High revenue growth: 19.9%, Low dividend (reinvesting): 0.0%, Low P/E: 13.6x, Strong ROE: 29.3%, Compounder growth range: 19.9%

What do Wall Street analysts say about INCY?

22 Wall Street analysts have a consensus price target of $108.50 for INCY, representing +13.2% upside. Targets range from $90.00 to $135.00. The consensus recommendation is "Buy". Our model is slightly more bullish than Wall Street.

What are the risks of investing in INCY?

The risk/reward asymmetry ratio for INCY is 10.00:1, rated as Very Favorable. Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside. The expected return is +109.4%, with bull case upside of +200.0% and bear case downside of -10.0%.

What is the current trend for INCY?

INCY is in a bullish trend. Price ($96.00) is 1.0% above SMA 200 ($95.06). Bullish trend confirmed. The technical score is 73/100.

Related Stock Analyses

Best Stocks to Buy

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.